Role of Bactiguard Infection Technology in Preventing Catheter-Associated Urinary Tract Infections
DOI:
https://doi.org/10.17140/CTPOJ-2-108Keywords:
Bactiguard infection technology (BIP), Catheter associated urinary tract infection (CAUTI), BiofilmAbstract
To study the role of bactiguard infection technology (BIP) in preventing Catheter-associated urinary tract infections. This study
was conducted in a tertiary care centre in the Department of Plastic Surgery, JIPMER, Pondicherry, India in the month of
August 2019. The study subject was a 55-year-old gentleman with Fournier’s gangrene and type 2 diabetes mellitus (DM). The
Foley’s catheter with BIP technology was used and its role in preventing urinary tract infections (UTI) was studied over a period
of 10-days. During the period of the catheter use in our subject, patient did not develop features of urinary tract infections.
BIP technology is claimed to be effective in preventing Catheter-associated urinary tract infections but further studies in more
individuals is required to validate the same.
References
World Health Organization (WHO). Health care without avoid-able infections: The critical role of infection prevention and con-trol. 2016.
Klevens RM, Edwards JR, Richards CL, et al. Estimating health-care associated infections and deaths in US hospitals, 2002. Public Submit your article to this journal | https://openventio.org/submit-manuscript/ Case Report | Volume 2 | Number 1 | Chittoria RK et al Health Rep. 2007; 122: 160-166. doi: 10.1177/003335490712200205
Schumm K, Lam TB. Types of urethral catheters for manage-ment of short-term voiing problems in hospitalised adults. Cochrane Database Syst Rev. 2008; (2): CD004013. doi: 10.1002/14651858. CD004013.pub3
Kizilbash QF, Petersen NJ, Chen GJ, Naik AD, Trautner BW. Bacteremia and mortality with urinary catheter-associated bac-teriuria. Infect Control Hosp Epidemiol. 2013; 34: 1153-1159. doi: 10.1086/673456
Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis. 1999; 29(2): 239-244. doi: 10.1086/520192
Albanèse J, Leone M, Garnier F, Bourgoin A, Antonini F, Mar-tin C. Renal effects of norepinephrine in septic and nonseptic pa-tients. 2004; 126: 534-539. doi: 10.1378/chest.126.2.534
Hugonnet S, Sax H, Eggimann P, Chevrolet J-C, Pittet D. Noso-comial bloodstream infections and clinical sepsis. Emerg Infect Dis. 2004; 10(1): 76-81. doi: 10.3201/eid1001.030407
Beiko DT, Knudsen BE, Watterson JD, Cadieux PA, Reid G, Denstedt JD..Urinary tract biomaterials. J Urol. 2004; 171: 2438- 2444. doi: 10.1097/01.ju.0000125001.56045.6c
Magnusson B, Kai-Larsen Y, Granlund P, et al. Long-term use of noble metal alloy coated urinary catheters reduces recurrent CAU-TI and decreases proinflammatory markers. Ther Adv Urol. 2019; 11: 1756287219854915. doi: 10.1177/1756287219854915
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Clinical Trials and Practice – Open Journal (CTP) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
